We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial.
- Authors
Webster, Linda J; Michelakis, Evangelos D; Davis, Terry; Archer, Stephen L
- Abstract
Erectile dysfunction (ED) is common in patients with congestive heart failure (CHF) and is often associated with symptoms of depression. Although sildenafil citrate, a phosphodiesterase 5 inhibitor, is effective in treating ED, its use is considered a relative contraindication in CHF. We hypothesized that sildenafil is a safe and effective treatment for ED in patients with New York Heart Association classes II and III CHF and that treatment of ED will improve symptoms of depression and enhance perceived of quality of life.
- Publication
Archives of internal medicine, 2004, Vol 164, Issue 5, p514
- ISSN
0003-9926
- Publication type
Journal Article
- DOI
10.1001/archinte.164.5.514